We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VPK:EURONEXT AMSTERDAMRoyal Vopak NV Analysis

Data as of 2026-03-15 - not real-time

€47.88

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Koninklijke Vopak shows a clear bullish bias as the short‑term moving average sits above the longer‑term averages, reinforcing the upward momentum. The RSI is perched in overbought territory, suggesting short‑term caution despite the strong trend. A very low beta underscores the stock’s defensive character relative to the broader market. Valuation metrics indicate the price is comfortably below peers, with a dividend yield that stands out as attractive and a modest payout ratio that supports sustainability. Recent record financial results and a newly announced multi‑year share buyback program add to the positive sentiment. However, revenue contraction and a high debt‑to‑equity ratio temper enthusiasm.
The sector’s cyclicality and regulatory environment present moderate headwinds, yet Vopak’s diversified terminal portfolio and strategic moves into low‑carbon solutions provide a solid long‑term foundation. Liquidity remains adequate despite a slight dip in volume, and the stock trades near its recent resistance, limiting upside in the immediate horizon. Overall, the combination of strong cash generation, defensive risk profile, and shareholder‑friendly actions make Vopak a compelling value play with attractive dividend income.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI in overbought zone
  • price near resistance level
  • share buyback providing near‑term support

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • undervalued relative to industry peers
  • high, sustainable dividend yield
  • strong operating cash flow and low beta

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • strategic positioning in energy transition infrastructure
  • consistent dividend policy
  • robust terminal network with diversified clientele

Key Metrics & Analysis

Financial Health

Revenue Growth-3.30%
Profit Margin46.09%
P/E Ratio9.2
ROE19.01%
ROA3.43%
Debt/Equity83.05
P/B Ratio1.7
Op. Cash Flow€900.1M
Free Cash Flow€64.4M
Industry P/E22.2

Technical Analysis

TrendBullish
RSI71.7
Support€42.88
Resistance€48.52
MA 20€45.86
MA 50€42.98
MA 200€40.64
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Target Price€51.10
Upside/Downside6.73%
GradeUndervalued
TypeValue
Dividend Yield3.76%

Risk Assessment

Beta0.14
Volatility25.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.